Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Cyclizine→

Cyclizine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
82-92-8
Molecular formula
C18H22N2
Molecular weight
266.3807 g/mol
Drug class
First-generation piperazine antihistamineH1 receptor antagonist with antiemetic activity
Mechanism of action
Antagonises central histamine H1 receptors and has anticholinergic activity, reducing vestibular stimulation and signalling in emetic pathways.
Indications / reported uses
  • Prevention and treatment of nausea, vomiting and motion sickness
  • Treatment of nausea and vomiting associated with vertigo or other vestibular disorders; formulation and indication are jurisdiction-specific

Sources: NHS — Cyclizine · NLM MeSH — Cyclizine · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Cyclizine Environmental Risk Assessment (ERA) (the Cyclizine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.